Gina Gotthardt Presents Research at Keystone Symposia 2026

We are proud to share that Gina Gotthardt, a PhD researcher in the group of Stefan Müller and member of UbiQancer, was selected to present her research on “Targeted Degradation of E3 Ligase Functions in Acute Myeloid Leukemia” at the Keystone Symposia “Proximity Based Biology and Therapeutics: Targeted Protein Degradation and Beyond” last week in Banff, Canada.

Being selected to present at this prestigious international conference is a remarkable recognition of Gina’s research and its contribution to the field of targeted protein degradation. Congratulations to Gina on this achievement!